The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma.

By G. Toyokawa, K. Taguchi, M. Edagawa, S. Shimamatsu, R. Toyozawa, K. Nosaki, F. Hirai, M. Yamaguchi, M. Shimokawa, T. Seto and 4 more. 2016

10 citations recorded by the source corpus.